Will DocuSign report Q1 FY2027 revenue growth above 8% year-over-year?

Historical base rate: DocuSign has delivered 7.8%-8.6% revenue growth in every quarter of FY2026. Three of four quarters were at or above 8%. The only sub-8% quarter was Q4 at 7.8%, which was distorted by tough comps and timing. The base rate of clearing 8% in any given quarter is approximately 75% from recent history alone. However, management's Q1 guidance of $822-826M already implies 10.2-10.7% growth — well above 8%. Even at the guidance floor of $822M, that is +10.2% YoY. The question becomes whether DocuSign can hit its own guidance, not whether growth can reach 8%. Given the company has never meaningfully missed quarterly guidance in recent history, the base rate for meeting guidance is very high (~90%+). Discounting for the FX headwind and professional services drag, probability lands around 82%.

Extrapolating the quarterly revenue growth trend: Q1=7%, Q2=8%, Q3=8%, Q4=7.8%. The average is approximately 7.7%. This gives a slightly more pessimistic read — the trend is stable at 8% but not accelerating. However, the critical framing shift is that management guided Q1 at $822-826M, which is 10%+ growth. Even accounting for typical over-delivery of guidance, the floor is well above 8%. The FX headwind of 1.6% is the main risk — it could shave $13M off revenue. But even if guidance is missed by the full FX impact, $822M - $13M = $809M, still above $805.9M. The base rate analysis suggests ~78% probability.

The base rate framing is clear: this market resolves YES unless DocuSign misses its own Q1 guidance by more than 2.4% ($824M midpoint vs $805.9M threshold). In DocuSign's recent history, the company has never missed quarterly guidance by that magnitude. Q4 FY2026 beat by $8-12M, Q3 showed a similar pattern. The deferred revenue balance of $1,661M provides strong near-term coverage. Even in a stress scenario where organic growth disappoints and FX drags harder than expected, the $18M buffer between guidance midpoint and threshold makes a NO outcome unlikely. Base rate probability: 80%.

Management guidance analysis: Q1 FY2027 guided at $822-826M. CFO described guidance philosophy as 'forecast and communicate what we see in the business' — implying realistic, not aspirational, targets. Yet DocuSign has consistently beaten guidance: Q4 beat by $8-12M, full-year beat by $7-11M. If the pattern holds, actual Q1 would be ~$830-836M, implying ~11.2-12.0% growth — massively above 8%. Even at the absolute floor of guidance ($822M), growth is 10.2%. The only scenario for NO is a catastrophic miss of guidance by $16M+ — unprecedented for DocuSign. Management's conservative guidance philosophy combined with consistent beats makes 85% probability appropriate.

Guidance implies management sees at least $822M in Q1 revenue. This is consistent with their ARR guidance of 8.25-8.75% growth, which signals modest underlying improvement. The question is essentially: can DocuSign avoid a >2.4% guidance miss? Management's track record of guidance accuracy is very strong. The only bear case is that Q1 FY2026 had a digital add-on tailwind creating a tough comparable, combined with FX headwind. But even if these factors collectively drag revenue down $10-12M below guidance midpoint, the result would be ~$812-814M — still above $805.9M. The guidance analysis strongly supports YES at 83%.

A more cautious read of guidance: CFO noted 'half of Q4 billings outperformance was timing' — suggesting some Q4 strength was pulled forward from Q1. If $4-5M of Q1 subscription revenue was pulled into Q4 through billings timing, Q1 actual could come in at the low end of guidance (~$822M) rather than beating it. Additionally, the FX headwind of 1.6% vs Q4's 0.8% tailwind represents a 2.4pp swing. In constant currency terms, Q1 would need to deliver stronger organic growth to match Q4's reported number. Still, even with these drags, $822M / $746.2M = 10.2%, well above 8%. Probability: 79%.

Cross-signal analysis: Multiple signals converge toward YES. (1) Deferred revenue grew 12.5% — the strongest leading indicator for near-term revenue, significantly above the 8% revenue growth rate. (2) Billings grew 10% in Q4 — typically leads revenue by 1-2 quarters. (3) Partner-contributed bookings grew >30% YoY in Q4 — channel diversification adds resilience. (4) CFO's Q1 share repurchase of $158M via 10b5-1 suggests internal confidence. The only negative cross-signal is professional services decline (-8.6% FY2026), but professional services is <5% of total revenue. Net cross-signal assessment: strong convergence toward YES at 84%.

Cross-signal analysis with a more skeptical lens: (1) Non-IAM ARR is 'structurally flat' per CFO — the core eSign business isn't growing, and IAM is still small. (2) Consumption pricing launches Q1 but ramp will be slow — likely negligible revenue impact. (3) The Myth Meter found NARRATIVE_REALITY_GAP = DIVERGING at HIGH confidence — management consistently overstates growth direction. However, these signals are about acceleration narrative, not about whether 8% growth can be maintained. The threshold is low enough that even flat execution delivers YES. The skeptical read is that DocuSign is a high-quality 8% grower being priced for acceleration, but 8% is still above the 8% threshold. Cross-signal probability: 77%.

Cross-signal synthesis: The strongest negative signal is the FX headwind (1.6% drag), but this has already been incorporated into management's guidance of $822-826M. Management would not guide $822-826M if they believed FX would drag them below that range. The consumption pricing launch, partner channel momentum, and deferred revenue coverage all point to Q1 being at or above guidance. The 8% threshold requires revenue of only $805.9M — the guidance floor of $822M already provides a $16.1M buffer. For NO to occur, something truly unexpected would need to happen: a major customer churn event, macro shock affecting enterprise spending, or accounting restatement. None of these appear on the horizon. Cross-signal probability: 81%.